These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33833760)

  • 1. Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice.
    Schuhmachers P; Münz C
    Front Immunol; 2021; 12():640918. PubMed ID: 33833760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
    Böni M; Rieble L; Münz C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized mouse models for Epstein Barr virus infection.
    Münz C
    Curr Opin Virol; 2017 Aug; 25():113-118. PubMed ID: 28837889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
    White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
    J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.
    Linke-Serinsöz E; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2017 Jul; 34(4):352-363. PubMed ID: 28506687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
    McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV infection of B cells primes protective T cell responses in humanized mice.
    Caduff N; Rieble L; Böni M; McHugh D; Roshan R; Miley W; Labo N; Barman S; Trivett M; Bosma DMT; Rühl J; Goebels N; Whitby D; Münz C
    Nat Commun; 2024 Jun; 15(1):4841. PubMed ID: 38844783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated lymphomas.
    Shannon-Lowe C; Rickinson AB; Bell AI
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity in Epstein Barr virus specific immune control.
    Münz C
    Curr Opin Virol; 2021 Feb; 46():1-8. PubMed ID: 32771660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
    Münz C
    Front Immunol; 2020; 11():581419. PubMed ID: 33013936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
    Damania B; Münz C
    FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) and lymphomagenesis.
    Cesarman E
    Front Biosci; 2002 Feb; 7():e58-65. PubMed ID: 11815280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.